Health Trials

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE

The purpose of this study is to prove the non-inferiority of a 6-weeks treatment with 1 mg budesonide orodispersible tablets BID versus 2 mg budesonide orodispesible tabletss for the induction of clinico-pathological remission in adult patients with active eosinophilic esophagitis.

Participants needed: 308
Trial details
Phase: Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: Dr. Falk Pharma GmbHUpdated: Apr 27, 2026Locations: 26
Eligibility criteria

Signed informed consent, [+4]

Clinical and endoscopic signs of gastroesophageal reflux disease (GERD), [+10]

Read more
Status: Recruiting

Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease

A study to discover if ZED1227 can improve continued celiac disease symptoms despite a gluten-free diet

Participants needed: 356
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Dr. Falk Pharma GmbHUpdated: Apr 2, 2026Locations: 1
Eligibility criteria

Signed informed consent [+4]

Presence of hypo- or hyperthyroidism. A patient with a well-controlled thyroid d... [+4]

Read more
Status: Not yet recruiting

Study with Norucholic Acid Tablets in Patients with Primary Sclerosing Cholangitis (PSC)

Open-label, multi-center, phase III trial. Oral treatment with 1500 mg norucholic acid in Primary Sclerosing cholangitis

Participants needed: 120
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Dr. Falk Pharma GmbHUpdated: Mar 20, 2025
Eligibility criteria

Signed informed consent. [+2]

History or presence of chronic alcoholic consumption (daily consumption > 30 g i... [+3]

Read more